We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of h... read more Featured Products: More products

Download Mobile App




Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business

By MedImaging International staff writers
Posted on 22 Oct 2024
Print article
Image: The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure (Photo courtesy of Gynesonics)
Image: The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure (Photo courtesy of Gynesonics)

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Gynesonics (Redwood City, CA, USA) for approximately USD 350 million, subject to working capital and other customary closing adjustments.

Gynesonics is a privately held medical device company dedicated to developing minimally invasive solutions for women’s health. The company pioneered and launched the Sonata System, which is the first FDA-cleared medical device designed for diagnostic intrauterine imaging and transcervical treatment of specific symptomatic uterine fibroids, including those linked to heavy menstrual bleeding. The Sonata System is unique as the world’s first and only intrauterine fibroid ablation system that combines the safety of ultrasound guidance with the established benefits of targeted radiofrequency energy, all within a single transcervical, incision-less procedure. The transcervical delivery method avoids entering the peritoneal cavity and does not necessitate general anesthesia. The Sonata System is capable of treating most types of fibroids, including submucous, intramural, transmural, and subserous fibroids, providing a groundbreaking alternative to traditional hysterectomy and myomectomy. The acquisition of Gynesonics strengthens Hologic’s innovative portfolio of medical technologies that effectively detect, diagnose, and treat women's health conditions.

“Gynesonics’ Sonata System complements our offering and will give GYN surgeons across the globe an expanded range of options to treat women suffering from heavy periods and fibroids,” said Brandon Schnittker, Division President of Surgical Solutions at Hologic. “This acquisition furthers our commitment to providing women with minimally invasive treatment options. We are enthusiastic about the future as we work to expand access to and drive innovation for treatments that enhance women’s quality of life.”

Related Links:
Hologic
Gynesonics

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Endoscopic Ultrasound Fine Needle Biopsy Device
Acquire
New
Gold Member
X-Ray QA Meter
T3 RG Pro
Wall Fixtures
MRI SERIES

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: Wearable ultrasound device offers continuous, long-term monitoring of muscle activity (Photo courtesy of Muyang Lin/UC San Diego)

Wearable Ultrasound Device Provides Long-Term, Wireless Muscle Monitoring

Electromyography (EMG) is the current clinical standard for monitoring muscle activity, utilizing metal electrodes placed on the skin to capture electrical signals from muscles. Despite its long-standing... Read more

Nuclear Medicine

view channel
Image: PET scans of a glioblastoma patient\'s brain, 72 hours after injection with the radiotracer (Photo courtesy of Dr Gabriela Kramer-Marek, The Institute of Cancer Research, London)

New Immuno-PET Imaging Technique Identifies Glioblastoma Patients Who Would Benefit from Immunotherapy

Glioblastoma is a type of brain tumor associated with a very poor prognosis, with average survival rates of 12 to 18 months and only 5% of patients surviving beyond five years. Research has shown that... Read more

General/Advanced Imaging

view channel
Image: Heavy smokers can ben Image (2):	efit from lung cancer screening using low-dose CT (Photo courtesy of 123RF)

Low-Dose CT Screening for Lung Cancer Can Benefit Heavy Smokers

Lung cancer is often diagnosed at a late stage, with only about one-fifth to one-sixth of patients surviving five years after diagnosis. A new report now suggests that low-dose computed tomography (CT)... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The advocacy partnership aims to help accelerate access to life-saving treatments (Photo courtesy of Philips)

Philips and Medtronic Partner on Stroke Care

A stroke is typically an acute incident primarily caused by a blockage in a brain blood vessel, which disrupts the adequate blood supply to brain tissue and results in the permanent loss of brain cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.